Thursday, 19 July 2018

Roche gets breakthrough status for Alzheimer's test Elecsys

The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)